Cargando…

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing

Detalles Bibliográficos
Autores principales: Kohli-Pamnani, Anita, Zapata, Kristen, Gibson, Tiffany, Kwittken, Pamela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413483/
https://www.ncbi.nlm.nih.gov/pubmed/34487840
http://dx.doi.org/10.1016/j.anai.2021.08.417
_version_ 1783747669838004224
author Kohli-Pamnani, Anita
Zapata, Kristen
Gibson, Tiffany
Kwittken, Pamela L.
author_facet Kohli-Pamnani, Anita
Zapata, Kristen
Gibson, Tiffany
Kwittken, Pamela L.
author_sort Kohli-Pamnani, Anita
collection PubMed
description
format Online
Article
Text
id pubmed-8413483
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84134832021-09-03 Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing Kohli-Pamnani, Anita Zapata, Kristen Gibson, Tiffany Kwittken, Pamela L. Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-01 2021-09-03 /pmc/articles/PMC8413483/ /pubmed/34487840 http://dx.doi.org/10.1016/j.anai.2021.08.417 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Kohli-Pamnani, Anita
Zapata, Kristen
Gibson, Tiffany
Kwittken, Pamela L.
Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title_full Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title_fullStr Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title_full_unstemmed Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title_short Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
title_sort coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413483/
https://www.ncbi.nlm.nih.gov/pubmed/34487840
http://dx.doi.org/10.1016/j.anai.2021.08.417
work_keys_str_mv AT kohlipamnanianita coronavirusdisease2019vaccinehypersensitivityevaluatedwithvaccineandexcipientallergyskintesting
AT zapatakristen coronavirusdisease2019vaccinehypersensitivityevaluatedwithvaccineandexcipientallergyskintesting
AT gibsontiffany coronavirusdisease2019vaccinehypersensitivityevaluatedwithvaccineandexcipientallergyskintesting
AT kwittkenpamelal coronavirusdisease2019vaccinehypersensitivityevaluatedwithvaccineandexcipientallergyskintesting